Tolazoline

Tolazoline is a medicine used to help with a specific lung condition in newborns. It works by relaxing blood vessels in the lungs, which helps blood flow better. It also helps the heart pump more blood. It's not a common medicine, but it's important for treating a serious lung problem in babies.

Brand names:Priscoline
Medication

What people taking Tolazoline report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Tolazoline

What It's For

Tolazoline is a vasodilator, a medicine that widens blood vessels. In people, its main use was in newborn intensive care units (NICUs) for persistent pulmonary hypertension of the newborn (PPHN). In PPHN, the blood vessels in a baby's lungs stay tight after birth instead of relaxing, so too little blood passes through the lungs to pick up oxygen and the baby's oxygen levels stay dangerously low. The human brand, Priscoline, is discontinued in the US, and tolazoline is now rarely used for people. Inhaled nitric oxide, a gas breathed in through the ventilator, became the FDA-approved standard treatment for PPHN largely because it relaxes lung blood vessels without lowering blood pressure in the rest of the body. Tolazoline still appears in older medical records, in some hospitals outside the US, and in veterinary medicine.

How It Works

Tolazoline blocks alpha-adrenergic receptors, the docking sites that let adrenaline-like signals tighten blood vessels, and it also acts through histamine receptors. The combined effect is that blood vessels relax. In a newborn with PPHN, relaxing the lung vessels can let more blood flow through the lungs and raise oxygen levels. The drawback is that tolazoline does not choose which vessels to relax. Given into a vein, it widens blood vessels throughout the body as well as in the lungs, which is the main reason it can drop blood pressure and why more targeted treatments replaced it.

Dosage & Administration

When it was used for PPHN, tolazoline was given by a neonatal team as an injection or continuous infusion into a vein, with the amount based on the baby's weight. It was never a medicine families gave at home. Some NICUs tried giving it directly into the breathing tube or as a mist, hoping more of the drug would reach the lungs and less would reach the rest of the body. These routes were studied only in small groups of babies and were never an approved way of giving it. Research also suggested that newborns clear tolazoline slowly, so the drug can build up during a long infusion.

Side Effects

The most important side effect is low blood pressure, because tolazoline widens blood vessels throughout the body. Flushing of the skin is also common. This is why it was used only in a NICU, where blood pressure is watched continuously. Tolazoline can also cause bleeding in the stomach or intestines, and rare reports describe a hole forming in the first part of the small intestine. Because newborns can accumulate the drug, effects on the heart were a further concern with higher doses.

Interactions & Warnings

When stomach bleeding occurs, acid-reducing medicines may be considered. One case report found that cimetidine, an acid-reducing medicine of the H2-blocker type, may weaken tolazoline's effect on the lungs, since part of tolazoline's action runs through the same histamine pathway. A veterinary form of tolazoline is FDA-approved for horses, where vets use it to reverse sedation from xylazine, an animal sedative. That product is not a human medicine and should never be used in people.

What to Expect

For a family whose baby has PPHN today, tolazoline is unlikely to be part of the plan in the US. Treatment usually centers on support for breathing and blood pressure, inhaled nitric oxide and, when needed, other medicines or heart-lung bypass (ECMO). If tolazoline was used, studies found that many, though not all, babies' oxygen levels improved at first, in responders often within about half an hour. The evidence comes from older small case series rather than large randomized trials, so it is uncertain how much tolazoline changes longer-term outcomes. Families who see it in an older child's medical records can ask the care team what was used and why.

Questions to Ask Your Doctor

  1. 1.What treatments are you using for my baby's pulmonary hypertension, and why were they chosen?
  2. 2.Is tolazoline or another older vasodilator being considered, and how does it compare with inhaled nitric oxide?
  3. 3.How will you watch my baby's blood pressure and check for stomach bleeding while on these medicines?
  4. 4.What follow-up will my baby need after leaving the NICU?

Last reviewed • Oct 2026

Educational content, not medical advice.